Herein, we aimed to systematically compare the plasma levels of NfL, GFAP, p-tau181, Aβ40, Aβ42, and Aβ42/40 among patients with early stages of MSA, PD, and SCA and healthy controls (HCs). Here, GFAP is linked to Parkinson disease.